1. Background {#sec1}
=============

Malaria is a common and fatal infectious parasitic disease \[[@B1], [@B2]\]. It is transmitted through*Anopheles* mosquitoes \[[@B3]--[@B6]\]. It was estimated that 214 million new malaria cases occurred worldwide in 2015 \[[@B2]\]. Malaria control and eradication are one of the major goals of the United Nation\'s Millennium Development Goals (MDG). In goal number 6, target 6C, the MDG aimed to halt by half and reverse the incidence of malaria by 2015 \[[@B7]\]. This goal was successfully achieved when the World Health Organization (WHO) reported that, between 2000 and 2015, malaria incidence rates and mortality rates fell significantly in "Africa, Southeast Asia (SEA) regions, Western Pacific region, Eastern Mediterranean region," and other regions in the world \[[@B8]\]. Vector control through insecticide-treated mosquito nets (ITNs) and indoor residual spraying (IRS) has contributed to the control and eradication of malaria in different world regions particularly in Africa \[[@B9]--[@B12]\]. Furthermore, the discovery of the effective drug artemisinin has greatly changed the therapeutic approach of malaria and enhanced control and eradication of malaria \[[@B13]--[@B15]\]. Artemisinin is isolated from the plant*Artemisia annua* employed in Chinese traditional medicine \[[@B16]\]. Actually, the Chinese scientist Tu Youyou, who discovered the drug artemisinin, was awarded Nobel Prize in Medicine in 2015 \[[@B17], [@B18]\]. Emergence of antimalarial drug resistance (AMDR), particularly for the core compound, artemisinin, is a new challenge for future plans to control malaria. In this regard, AMDR is defined as survival and multiplication of malaria parasite under conditions that normally stop and cure malaria infection \[[@B19]\]. One of the main advances in AMDR is the identification of mutations responsible for drug resistance \[[@B20]--[@B22]\]. Monitoring of AMDR is highly needed in order to adopt different control and therapeutic policies for malaria. Assessing research productivity on malaria in general and those pertaining to drug resistance in particular is extremely important. Such studies are carried out using bibliometric indicators that help identify research trends, hot research topics, international collaboration, and country contribution to the field. In fact several studies have been carried out using bibliometric indicators to assess malaria research in different parts of the world \[[@B23]--[@B29]\]. However, none was carried out on AMDR. Therefore, the aim of this study was to give a bibliometric overview of publications on AMDR. The focus of this study will be on documents published in the last decade (2006 to 2015) to give an insight into the most recent research activity in this field and future prospects in order to help health policy makers make future plans on malaria control more relevant.

2. Methods {#sec2}
==========

The method and indicators used in this study have been explained in detail in previously published bibliometric studies \[[@B30]--[@B38]\]. However, we will present and discuss the approach used in this study as an additional piece of information for readers and other investigators. Scopus, run by Elsevier, is one of the largest electronic databases available for literature retrieval. It is friendly to use and provides functions like "limit" and "exclude" that facilitates data refining and analysis. Furthermore, Scopus has the ability to provide researchers with citation analysis, country profile, institution profile, author profile, and source journals for any set of data in any particular field. Other databases can be used for data analysis and retrieval; however, Scopus remains superior to these databases in terms of volume of literature it has \[[@B39]\].

In this study, the keywords used in Scopus for retrieval of data were as follows: (TITLE("Plasmodium falciparum" OR "PLASMODIUM vivax" OR "Plasmodium malariae" OR "Plasmodium ovale" OR malaria OR "P. vivax" OR "P. falciparum" OR "P. malriae" OR "P. ovale") AND TITLE(" ^*∗*^aminoquinoline resist^*∗*^" OR " ^*∗*^chloroquine resist^*∗*^" OR "amodiaquine resist^*∗*^" OR "pyrimethamine resist^*∗*^" OR "mefloquine resist^*∗*^" OR "artemisinin resist^*∗*^" OR "piperaquine resist^*∗*^" OR "resist^*∗*^ malaria" OR "antimalarial drug resist^*∗*^") OR TITLE("proguanil resist^*∗*^" OR "sulf^*∗*^resist^*∗*^" OR "Atovaquone resist^*∗*^" OR "Primaquine resist^*∗*^" OR "Halofantrine resist^*∗*^" OR pfcrt^*∗*^ OR pfmdr^*∗*^ OR pfatp^*∗*^ OR pfnhe^*∗*^ OR "dhfr^*∗*^ mutation" OR "dhps^*∗*^ mutation" OR pfmrp OR pfdhfr OR pfdhps) OR TITLE(pfmrp^*∗*^ OR pfcytb^*∗*^ OR "Chloroguanide resist^*∗*^" OR "quinine resist^*∗*^" OR "Pyronaridine resist^*∗*^" OR "dihydroartem^*∗*^  resist^*∗*^" OR "arte^*∗*^  resist^*∗*^" OR "drug resist^*∗*^ malaria" OR "resist^*∗*^" OR pvcrt^*∗*^ OR pvmdr^*∗*^) AND TITLE(resist^*∗*^) AND NOT TITLE(insect^*∗*^ OR anopheles OR tuberculosis OR pyrethroid OR mosquito OR avian OR toxoplasma OR cytochrome OR salmonella OR fluoroquinolone OR antifungal OR snake OR organophosphate)) AND PUBYEAR \> 2005 AND PUBYEAR \< 2016 AND (LIMIT-TO(SRCTYPE, "j")) AND (EXCLUDE(DOCTYPE, "er")).

These keywords used in this study were chosen based on literature review pertaining to AMDR from all aspects including molecular biology and genetics. To maximize accuracy, all keywords were entered in title search and quotation marks were used wherever appropriate. The time limit of the study was from 2006 to 2015. For the purpose of this study, only journal articles were included in the analysis. Quantitative assessment of AMDR literature was simply carried out by analysis of volume of retrieved articles while scientific impact of the publication was presented as number of citations per article and number of highly cited articles as well as the impact factor (IF) of journals publishing the retrieved articles. The validity of our search query was tested and confirmed by manually reviewing 10% of top cited articles in the retrieved data. The manual review was carried by the authors themselves. Country affiliation analysis in Scopus can give researchers insight into intra- and intercountry collaboration. Single country publications (SCP) are those that represent intracountry collaboration while multiple country publications (MCP) are those that represent intercountry collaboration. We considered only the top ten ranking countries, institutions, and journals. To visualize country collaboration or coauthorships, VOSviewer was used \[[@B40]\]. VOSviewer can represent information as either density visualizations maps or network visualizations maps. In this study, we used density visualization map as cluster density maps. Each cluster represents group of most frequently and closely collaborating countries where countries having higher numbers of coauthorships are the ones with higher extent of collaboration.

3. Results {#sec3}
==========

A total of 976 journal documents were retrieved. Types of retrieved documents are listed in [Table 1](#tab1){ref-type="table"}. Original research articles (790; 80.94%) were the main type. A total of 12 different languages were encountered in the retrieved documents. English language (942; 96.52%) was most commonly encountered followed by French (16; 1.64%) and Chinese (6; 0.30%) languages. A total of 125 countries contributed to the publication of retrieved documents.

The growth of publications on AMDR showed a fluctuating pattern in the last decade ([Figure 1](#fig1){ref-type="fig"}). However, growth of publications showed a noticeable increase when data on AMDR was presented for the last five decades ([Figure 2](#fig2){ref-type="fig"}). The average number of publications was approximately 98 documents per year. [Table 2](#tab2){ref-type="table"} shows the number of publications, total citations, and average number of citations per article in each year for the last decade. The total number of citations of the retrieved documents was 21399 with an h-index of 63. VOSviewer technique was used to find out the most commonly encountered terms in title/abstract of retrieved documents after setting the minimum threshold at 10. The density visualization map yielded a total of 350 relevant terms distributed in three clusters shown in three different colors ([Figure 3](#fig3){ref-type="fig"}). Cluster number one (red) focuses on terms mainly related to chloroquine resistance (CQR) and the genetic basis behind CQR. The second cluster (green) focuses on antifolate drug resistance and the genetic basis of this resistance. The third cluster (blue) focuses on artemisinin related resistance and its geographical distribution in Asia and Africa. [Table 3](#tab3){ref-type="table"} lists the most frequent terms in each cluster and the number of occurrences of each term.

Geographical distribution of retrieved publications was presented in world map using ArcMap 10.1 program ([Figure 4](#fig4){ref-type="fig"}). Top countries that participated in publishing documents on AMDR were listed in [Table 4](#tab4){ref-type="table"}. The United States of America (USA) was the most productive country with 337 publications equivalent to one-third of worldwide publications in this field. The USA and the United Kingdom (UK) participated in more than half (55.23%) of worldwide productivity. More than two-thirds of publications by the USA (236, 70.03%) were made by international collaboration with researchers from other countries. All articles published by Cambodian researchers had international authors representing 100% international collaboration (MCP). Furthermore, articles published by Cambodian researchers had the highest number of citations per article when compared with articles published by other countries. Of the top productive countries, two countries were from Mekong subregion, particularly Thailand and Cambodia. Analysis of country coauthorships using VOSviewer showed a map with four clusters ([Figure 5](#fig5){ref-type="fig"}, [Table 5](#tab5){ref-type="table"}). Countries in the same cluster have higher collaboration than those distantly located in other clusters. Furthermore, countries with higher number of coauthorships had higher number of articles published on international collaboration.

Top journals in publishing documents about AMDR were listed in [Table 6](#tab6){ref-type="table"}. The Malaria Journal was the most productive journal (136, 13.93%) in this field followed by Antimicrobial Agents and Chemotherapy journal and American Journal of Tropical Medicine and Hygiene. The Proceedings of the National Academy of Sciences (PNAS) had the highest impact factor (9.423) and the highest number of citations per article (49.06). Journal of Infectious Diseases (70.00%) had the highest percentage of highly cited articles followed by PNAS (62.50%). The total number of articles published in the top 10 publishing journals was 450 (46.11%) and the total impact of these articles was 1,704 with an average of 3.79 per article.

Top productive institutions on AMDR were shown in [Table 7](#tab7){ref-type="table"}. The top productive institution was Mahidol University (80, 8.20%) in Thailand. Another institution in the top-ten list was Shoklo Malaria Research Unit in Thailand which was in the 8th position. Three of the top ten institutions active in AMDR research were in Asia, particularly in India and Thailand. Both World Health Organization (WHO) and Centers for Disease Prevention and Control (CDC) were among the top ten productive institutions. Citations per article were the highest for documents published from*Shoklo Malaria Research Center* (107.71) followed by those published by WHO (92.22). For all research institutions/organizations in top-ten list, artemisinin resistance and biomarkers for artemisinin resistance were their major research focus.

Top ten cited articles on AMDR published in the past decade were presented in [Table 8](#tab8){ref-type="table"}. The article "Artemisinin Resistance in*Plasmodium falciparum* Malaria" which received a total of 1350 citations at the time of data analysis (July 15, 2016) was the top cited article. Three articles in the top ten cited list were published in New England Journal of Medicine. Two of the top ten cited articles were published in Science and Nature, and one article was published in The Lancet. Seven articles in the top-ten list were about artemisinins resistance in*Plasmodium falciparum*, one was about CQR, one was about sulfadoxine-pyrimethamine resistance, and the remaining one was about general multidrug resistance.

Authors participating in publications of AMDR with at least 10 documents were shown in the VOSviewer visualization map ([Figure 6](#fig6){ref-type="fig"}). [Table 9](#tab9){ref-type="table"} lists authors with a minimum of 15 publications and their location in the map. The map contained seven clusters. The most productive authors were clustered together in cluster numbers 1 and 2 mainly.

4. Discussion {#sec4}
=============

In this study we aimed to give an overview and an assessment of an emerging important issue regarding antimalarial drug resistance which threatens global efforts to control and eradicate malaria. Although bark of cinchona tree and other related synthetic compounds had been used to treat malaria for centuries, the emergence of resistance to antimalarial drugs is considered relatively recent medical phenomenon. It has been reported that early cases of chloroquine-resistant form of*P. falciparum* appeared in Thailand in the late 1950s. In the 1960s more cases of resistant*P. falciparum*were seen in Southeast Asia followed by the appearance of resistant cases in Sub-Saharan Africa and South America in the 1970s. The spread of chloroquine resistance in the 1970s and 1980s led researcher to develop and introduce new antimalarial drugs to combat the increasing numbers of malaria induced mortality due to antimalarial drug resistance in*P. falciparum*\[[@B41]--[@B43]\]. Sulfadoxine-pyrimethamine, an alternative to chloroquine, faced drug-resistant*Plasmodium* species soon after introduction \[[@B44]\]. Unfortunately, most new attempts such as introduction of mefloquine, amodiaquine, and artemisinin faced the same problem of drug resistance with time. The fight against malaria recorded a success upon introduction of insecticide-treated bed nets and indoor residual insecticide spraying \[[@B45]\]. The origin and the emergence of resistance to antimalarial drugs has been developed mainly through genetic mutations which involved chloroquine resistance transporter (PfCRT),*Plasmodium falciparum* multidrug resistance gene-1 (PfMDR), dihydrofolate reductase (DHFR), dihydropteroate synthase (DHPS), and several others \[[@B46]\]. The genetic mutation that led to chloroquine resistance developed independently in Papua New Guinea, certain locations in South America, and Asia which then spread through Southeast Asia and Africa \[[@B47]--[@B49]\]. It is believed that spread of resistance to chloroquine did not emerge within infected individuals; rather, it was a spread of emerging mutations due to drug pressure \[[@B46]\]. This hypothesis was tested by removal of drug pressure which led to a decrease in the prevalence of the PfCRT 76T mutation associated with chloroquine resistance \[[@B50]\]. Resistance in*P. falciparum* is complicated by increasing resistance to artemisinin partner drugs such as piperaquine. Molecular markers for drug resistance are currently used for monitoring expected therapeutic outcomes and for directing policy changes towards suitable combination therapies. Markers are available for artemisinin resistance, mefloquine resistance, and recently piperaquine resistance (*plasmepsin 2* and*plasmepsin 3* gene amplifications on chromosome 14) \[[@B51], [@B52]--[@B54]\].

Our study showed that the number of publications on AMDR was fluctuating in the last decade. However, when the number of publications on AMDR was presented for the past five decades, it was apparent that there was an overall increase in the number of publications in the past decade. It was expected that publications on AMDR will decrease with time especially after the introduction of artemisinins as new potent and effective therapy for malaria. However, the emergence of resistance to artemisinins kept the number of publications on AMDR rising with time \[[@B55]--[@B59]\]. This new wave of AMDR is accompanied by global concern regarding attaining goals of malaria control in Africa, Asia, and other regions.

The*Global Technical Strategy for Malaria 2016--2030* aimed at reducing incidence, mortality, and resurgence of malaria in endemic countries. This ambitious goal is costly but will save lives and have a cost-effective long term outcome. The emergence of AMDR in general and those pertaining to artemisinin in particular threatens the*Global Technical Strategy for Malaria 2016--2030*. Unfortunately, AMDR reports in the past decade originated from areas suffering from poor health services and depending on international health aids to combat malaria such as some African countries or countries in the Mekong region \[[@B60]\]. The emergence of AMDR is considered a recent phenomenon relative to the long history and extensive use of antimalarials in different parts of the world. Such AMDR were reported in the late 1950s and showed a marked increase and spread in 1970, particularly for those pertaining to chloroquine. This emergence of AMDR was associated with increased malaria rate of death and increased calls by health policy makers and international health organization to discover new antimalarial drugs that are not prone to resistance \[[@B41], [@B61]\]. In response to this serious threat of AMDR, the*International Centers of Excellence for Malaria Research* (*ICEMRs*) had developed an ICEMR network to monitor AMDR at global level \[[@B20]\].

The global concern on AMDR is manifested in the high h-index value suggesting that there are many readers and citations on the topic. Another indicator for the global concern on AMDR is the top cited articles on AMDR which focused on artemisinin drug resistance in some poor and developing areas like Thailand, Cambodia, and Indonesia. Countries in SEA might be the source of artemisinin drug resistance outbreaks and consequent spread of this resistant to other world regions \[[@B63]\]. The genetic basis of artemisinin drug resistance was common in most areas being investigated in greater Mekong area and is associated with*PfKelch* gene on chromosome 13 (K13) \[[@B64]\]. The potential spread of artemisinin resistance to African countries and other world regions is considered a priority for many international health bodies like WHO. The strategic plan suggested by WHO to prevent the spread or emergence of new geographic spots of artemisinin resistance does not seem to be successful \[[@B65]\]. Understanding the genetic and genomic investigation and the elucidation of molecular markers to AMDR will, hopefully, help in designing new antimalarial drugs. For example, several new compounds are being tested after discovery and understanding of the role of pfcrt in drug resistance \[[@B66]\].

The density visualization maps shed lights on areas of interest on the field of AMDR. The genetic and molecular understanding of AMDR of chloroquine and DHFR inhibitors occupied a central part in the publications on AMDR in the last decade. However. The emerging artemisinins drug resistance also occupied a single large cluster of publications. The publications in the last decade were in the field of molecular biology/genetics of AMDR and characterization of artemisinins drug resistance. These important topics were important in ranking top productive countries. Therefore, developed countries in which molecular and genetic advancement and research are active occupied top ranking positions. Such countries include the USA and the UK. However, countries like Thailand, Cambodia, and India where mainly involved in research pertaining to epidemiology and characterization of the emerging artemisinins drug resistance in Asia region, particularly the Mekong region where malaria is endemic. Publications from Thailand and Cambodia were characterized by high citations per article suggestive of relatively high importance in the field. It seems that all or nearly most of the publications from Thailand and Cambodia came through international research collaboration since this topic is of a global concern and research collaboration in this field is highly needed. Also, the limited resources and expertise of countries in the SER relative to those in Europe and northern American countries made international collaboration a must in order to understand and overcome this serious threat of AMDR to ultimately control the fatal infectious disease of malaria. The research activity on AMDR in Thailand was carried out mainly by two institutions which are presented in the top ten productive institutions along with prestigious organizations and institutions like WHO and CDC.

The retrieved articles discussed various issues that cannot be listed here in detail. However, it is worth commenting on articles that discussed potential causes of AMDR. The WHO recommends artemisinin-based combination therapies (ACTs) for the treatment of malaria to minimize development of artemisinin drug resistance \[[@B67], [@B68]\]. The ACTs are considered first-line treatment of malaria in most countries and hundreds of millions of ACTs treatment courses were dispensed in the past few years in endemic countries \[[@B68]\]. Therefore drug use without appropriate combination is one mechanism responsible for the development of AMDR \[[@B69]\]. Furthermore, unregulated and irrational use of antimalarial drug use as well as counterfeit and poor quality medicines dispensed in Africa and other parts of the world might be responsible for the spread and development of AMDR \[[@B70]--[@B72]\]. Genetic variations of malaria parasites from one region to another are also a potential cause for the development and resistance of AMDR \[[@B41], [@B73], [@B74]\].

This study, to the authors\' best knowledge, is the first to discuss the AMDR from a bibliometric analysis point of view. However, few limitations pertaining to the study need to be mentioned which have already been mentioned in previous bibliometric studies published by the authors \[[@B75]--[@B82]\]. An important limitation is the keywords used which might not be 100% comprehensive and therefore false positive and false negative results are possible. Also, data were retrieved from Scopus and, unfortunately, this does not represent 100% of literature because some journals are not indexed in Scopus. Finally, we analyzed the scientific impact of top ten countries, journals, and institutions and not all data. Despite all this, the authors did their best to validate the data by manual review and tried to give a close overall assessment on ADMR research productivity that hopefully will be a positive addition to the literature on AMDR.

5. Conclusion {#sec5}
=============

This study showed an increased interest in the artemisinin drug resistance as well as molecular biology and genetics of AMDR in general. Countries and institutions in the Mekong subregion had a good share of publication on AMDR. International collaboration is of great value and can enhance the quantity and scientific impact of publications on AMDR, particularly in countries with limited resources like the case of some Asian countries. Articles on AMD have been published in prestigious journals with high IF indicative of the global concern and dimension of the AMDR issue.
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![Density visualization map for researchers\' coauthorships on AMDR (2006--2015). A minimum of 10 yielded 63 authors.](MRT2017-6429410.006){#fig6}

###### 

Types of retrieved documents on AMDR (2006--2015).

  ------------------------------------------
  Type of document   Frequency   % \
                                 *N* = 976
  ------------------ ----------- -----------
  Article            790         80.94

  Review             92          9.43

  Letter             31          3.18

  Note               24          2.46

  Short survey       18          1.84

  Editorial          9           0.92

  Conference paper   6           0.61

  Article in press   6           0.61
  ------------------------------------------

AMDR: antimalarial drug resistance.

###### 

Growth of annual publications and citations on AMDR (2006--2015).

  Year   Total number = 976   \%      TC     C/A     CT
  ------ -------------------- ------- ------ ------- -------
  2015   109                  11.17   608    5.58    21399
  2014   105                  10.76   1113   10.60   20791
  2013   104                  10.66   1032   9.92    19678
  2012   89                   9.12    1834   20.61   18646
  2011   98                   10.04   1847   18.85   16812
  2010   101                  10.35   1892   18.73   14965
  2009   108                  11.07   4635   42.92   13073
  2008   72                   7.38    2626   36.47   8438
  2007   101                  10.35   3100   30.69   5812
  2006   89                   9.12    2712   30.47   2712

AMDR: antimalarial drug resistance; TC: total citations; C/A: citations per article; h-index: Hirsh index; CT: cumulative citations.

###### 

Most frequent terms in title/abstract of publications on AMDR (2006--2015) using VOSviewer technique.

  Terms related to drug resistance, gene mutations, or countries   Number of occurrences
  ---------------------------------------------------------------- -----------------------
  *Cluster \# 1 (red) = 138 items*                                  
  Chloroquine resistance transporter                               20
  Chloroquine-resistant                                            15
  Chloroquine-resistant malaria                                    21
  Chloroquine-resistant *P. falciparum*                            11
  Chloroquine-resistant parasites                                  12
  Chloroquine-resistant *Plasmodium falciparum*                    26
  Chloroquine-resistant strain                                     20
  CQR (chloroquine resistance)                                     38
  pfcrt mutation                                                   15
  Transporter                                                      38
  Protein                                                          92
  Phenotype                                                        62
                                                                   
  *Cluster \# 2 (green) = 123 items*                                
  Antifolate drug resistance                                       25
  dhfr gene                                                        18
  dhps gene                                                        33
  dhps mutation                                                    18
  pfdhps gene                                                      20
  Pyrimethamine resistance                                         38
  pfcrt gene                                                       39
  pfmdr1 gene                                                      35
                                                                   
  *Cluster \# 3 (blue) = 89 items*                                  
  Artemisinin resistance                                           90
  Artemisinin-resistant malaria                                    17
  Sub-Saharan Africa                                               23
  Thai-Myanmar border                                              10
  Papua                                                            15
  Asia                                                             81

AMDR: antimalarial drug resistance.

###### 

Top ten productive countries, scientific impact, and international collaboration on AMDR (2006--2015).

  -----------------------------------------------------------------------------------------------
  Rank   Country          Frequency \   TC     C/A     h-index   CC   SCP           MCP
                          *N* = 976                                                 
  ------ ---------------- ------------- ------ ------- --------- ---- ------------- -------------
  1st    United States    337 (34.53)   9498   28.18   50        73   101 (29.97)   236 (70.03)

  2nd    United Kingdom   202 (20.70)   8702   43.08   48        69   15 (7.43)     187 (92.57)

  3rd    Thailand         129 (13.22)   6736   52.22   39        51   30 (23.26)    99 (76.74)

  4th    France           90 (9.22)     2463   27.37   28        61   19 (21.11)    71 (78.89)

  5th    India            89 (9.12)     1280   14.38   18        30   65 (73.03)    24 (26.97)

  6th    Australia        79 (8.09)     3054   38.66   28        45   10 (12.66)    69 (87.34)

  7th    Cambodia         49 (5.02)     4645   94.80   27        45   0 (0.00)      49 (100.00)

  7th    Switzerland      49 (5.02)     3143   64.14   22        45   0 (0.00)      49 (100.00)

  9th    Germany          46 (4.71)     1255   27.28   25        54   8 (17.39)     41 (89.13)

  10th   Portugal         42 (4.30)     970    23.10   16        29   3 (7.14)      39 (92.86)
  -----------------------------------------------------------------------------------------------

AMDR: antimalarial drug resistance; *N*: total number of publications; TC: total citations; h-index: Hirsch index; CC: cumulative citations; SCP: single country publications; MCP: multiple country publications.

###### 

Country coauthorship as retrieved by VOSviewer. A minimum of 10 gave a total of 51 items and 4 clusters.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Cluster number          Items (number of country coauthorships)
  ----------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Cluster \# 1 (red)\     Belgium (31), Burkina Faso (94), Cameroon (53), Denmark (61), Ethiopia (47), France (182), Gambia (67), Ghana (79), Italy (29), Kenya (112), Madagascar (45), Malawi (47), Mali (76), Netherlands (58), Nigeria (80), Senegal (42), South Africa (47), Sudan (69), Tanzania (121), Uganda (63), United Kingdom (518).
  21 items                

  Cluster \# 2 (green)\   Brazil (35), China (33), Egypt (17), Iran (8), Japan (66), Malaysia (10), Pakistan (13), Papua New Guinea (53), Portugal (77), Spain (27), Sweden (125), USA (529), Yemen (10).
  13 items                

  Cluster \# 3 (blue)\    Austria (32), Bangladesh (60), Cambodia (203), Congo (70), Laos (76), Myanmar (56), Singapore (56), Switzerland (158), Thailand (312), Vietnam (69).
  10 items                

  Cluster \# 4\           Australia (197), Canada (47), Colombia (15), Germany (109), India (62), Indonesia (86), Israel (16).
  (yellowish green)\      
  7 items                 
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Top ten journals in publishing articles on AMDR (2006--2015).

  -------------------------------------------------------------------------------------------------------------------------------------
  Rank   Journal                                             Frequency (%) \   TC     h-index   C/A     HC (%)       IF      Total IF
                                                             *N* = 976                                                       
  ------ --------------------------------------------------- ----------------- ------ --------- ------- ------------ ------- ----------
  1st    Malaria Journal                                     136 (13.93)       1860   22        13.68   29 (21.32)   3.079   418.744

  2nd    Antimicrobial Agents and Chemotherapy               96 (9.84)         2017   27        21.01   41 (42.71)   3.34    320.64

  3rd    American Journal of Tropical Medicine and Hygiene   56 (5.74)         1124   19        20.07   19 (33.93)   2.699   151.144

  4th    Plos One                                            38 (3.89)         733    16        19.29   13 (34.21)   3.54    134.52

  5th    Journal of Infectious Diseases                      30 (3.07)         997    21        33.23   21 (70.00)   6.344   190.32

  6th    Acta Tropica                                        26 (2.66)         358    12        13.77   7 (26.92)    2.380   61.88

  7th    Infection Genetics and Evolution                    21 (2.15)         285    9         13.57   5 (23.81)    2.591   54.411

  8th    PNAS                                                16 (1.64)         785    12        49.06   10 (62.50)   9.423   150.768

  8th    Trends in Parasitology                              16 (1.64)         242    9         15.13   4 (25.00)    7.295   116.72

  10th   Emerging Infectious Diseases                        15 (1.54)         229    9         15.27   3 (20.00)    6.99    104.85

                                                                                                                             

         *Total*                                             *450 (46.11%)*                                                  *1,704*
  -------------------------------------------------------------------------------------------------------------------------------------

PNAS: Proceedings of the National Academy of Sciences of the United States of America; AMDR: antimalarial drug resistance; *N*: total number of publications; TC: total citations; h-index: Hirsch index; C/A: citations per article; IF: impact factor.

###### 

Top ten productive institutions in publishing articles on AMDR (2006--2015).

  Rank   Institution (affiliation)                                      Country     Frequency (%)   TC     C/A      h-index   HC (%)
  ------ -------------------------------------------------------------- ----------- --------------- ------ -------- --------- ------------
  1st    Mahidol University                                             Thailand    80 (8.20)       5197   64.96    34        38 (47.50)
  2nd    London School of Hygiene & Tropical Medicine                   UK          62 (6.35)       2033   32.79    25        21 (33.87)
  3rd    Oxford University (Nuffield Department of Clinical Medicine)   UK          45 (4.61)       1471   32.69    20        15 (33.33)
  4th    National Institute of Allergy and Infectious Diseases          USA         39 (4.00)       2247   57.62    23        21 (53.85)
  5th    National Institute of Malaria Research India                   India       37 (3.79)       2951   79.76    19        15 (40.54)
  6th    Organisation Mondiale de la Sante                              WHO         32 (3.28)       2951   92.22    19        15 (46.88)
  7th    Centers for Disease Control and Prevention                     USA         31 (3.18)       877    28.29    16        9 (29.03)
  7th    Menzies School Of Health Research                              Australia   29 (2.97)       1854   63.93    20        16 (55.17)
  9th    Shoklo Malaria Research Unit                                   Thailand    28 (2.87)       3016   107.71   20        19 (67.86)
  10th   University of California, San Francisco                        USA         26 (2.66)       691    26.58    15        10 (38.46)

TC: total citations; C/A: citations per article; h-index: Hirsch index; HC (%): percentage of articles with high citations.

###### 

Top cited articles on AMDR (2006--2015).

  Rank   Authors                       Title                                                                                                                                                           Source title                                  Number of citations
  ------ ----------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------- ---------------------
  1st    Dondorp et al. \[[@B83]\]     "Artemisinin Resistance in *Plasmodium falciparum* Malaria"                                                                                                     New England Journal of Medicine               1350
  2nd    Noedl et al. \[[@B84]\]       "Evidence of Artemisinin-Resistant Malaria in Western Cambodia"                                                                                                 New England Journal of Medicine               688
  3rd    Phyo et al. \[[@B85]\]        "Emergence of Artemisinin-Resistant Malaria on the Western Border of Thailand: A Longitudinal Study"                                                            The Lancet                                    354
  4th    Ariey et al. \[[@B51]\]       "A molecular Marker of Artemisinin-Resistant *Plasmodium falciparum* Malaria"                                                                                   Nature                                        319
  5th    Tjitra et al. \[[@B86]\]      "Multidrug-Resistant *Plasmodium vivax* Associated with Severe and Fatal Malaria: A Prospective Study in Papua, Indonesia"                                      PLoS Medicine                                 301
  6th    Ashley et al. \[[@B87]\]      "Spread of Artemisinin Resistance in *Plasmodium falciparum* Malaria"                                                                                           New England Journal of Medicine               263
  7th    Price et al. \[[@B88]\]       "New Developments in *Plasmodium vivax* Malaria: Severe Disease and the Rise of Chloroquine Resistance"                                                         Current Opinion in Infectious Diseases        197
  8th    Cheeseman et al. \[[@B89]\]   "A Major Genome Region Underlying Artemisinin Resistance in Malaria"                                                                                            Science                                       172
  9th    Ter Kuile et al. \[[@B90]\]   "Effect of Sulfadoxine-Pyrimethamine Resistance on the Efficacy of Intermittent Preventive Therapy for Malaria Control during Pregnancy: A Systematic Review"   Journal of the American Medical Association   170
  10th   Price et al. \[[@B91]\]       "Molecular and Pharmacological Determinants of the Therapeutic Response to Artemether-Lumefantrine in Multidrug-Resistant *Plasmodium falciparum* Malaria"      Clinical Infectious Diseases                  161

###### 

List of authors, number of coauthorships, and location in cluster as retrieved from VOSviewer. Researchers with a minimum of 15 documents on AMDR (2006--2015) were shown.

  Author              Number of publications   Number of coauthorships   Cluster
  ------------------- ------------------------ ------------------------- ---------
  Nosten, F.          35                       148                       2
  White, N. J.        28                       186                       2
  Imwong, M.          25                       131                       2
  Price, R. N.        25                       88                        7
  Roper, C.           23                       15                        1
  Plowe, C. V.        21                       74                        4
  Pradines, B.        21                       28                        5
  Dondorp, A. M.      20                       149                       2
  Rosenthal, P. J.    20                       22                        1
  Udhayakumar, V.     19                       31                        1
  Alifrangis, M.      17                       8                         1
  Kenangalem, E.      17                       55                        7
  Rogier, C.          17                       27                        5
  Meshnick, S. R.     16                       35                        1
  Ménard, D.          24                       41                        5
  Sutherland, C. J.   16                       22                        1
  Anstey, N. M.       15                       51                        7
  Fairhurst, R. M.    15                       81                        6
  Fidock, D. A.       15                       14                        3
  Na-Bangchang, K.    15                       3                         3
  Ringwald, P.        15                       70                        6
  Roepe, P. D.        15                       5                         3
  Wirth, D. F.        15                       6                         3

[^1]: Academic Editor: Sasithon Pukrittayakamee
